Home » Topics » Regulatory » Patents

Patents
RSS

New York Blood Center patents new antiviral compounds

March 11, 2022

Viva Star Biosciences synthesizes new LPAR1 antagonists

March 10, 2022

Bolt Biotherapeutics presents new antibody-drug conjugates

March 10, 2022

Prelude Therapeutics identifies CDK9 inhibitors

March 10, 2022

Abbisko Therapeutics divulges new FGFR inhibitors

March 10, 2022

Aligos Therapeutics patents PRMT5 inhibitors

March 10, 2022

TNIK Therapeutics presents new prodrugs of TNIK inhibitors

March 9, 2022

P2RX3 antagonists discovered at Tuojie Biotech

March 9, 2022

Nanjing Shunxin Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical Group patent ADCs

March 9, 2022

New ibuprofen derivatives divulged by Nanjing Heron Pharmaceutical Science and Technology

March 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...